Clinical Trial Update: Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus [NA]

View source ↗

Summary

A completed pilot study assessing whether oral controlled-release alpha-lipoic acid reduces oxidative stress in adolescents with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Alpha-Lipoic Acid (oral controlled-release) (alpha-lipoic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED